168 related articles for article (PubMed ID: 3159807)
1. Leprosy: altered complement receptors in disseminated disease.
Tausk F; Hoffmann T; Schreiber R; Gigli I
J Invest Dermatol; 1985 Jul; 85(1 Suppl):58s-61s. PubMed ID: 3159807
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
3. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
4. CR1 deficiency in patients with Hansen's disease.
Tausk FA; Schreiber RD; Gigli I
Trans Assoc Am Physicians; 1984; 97():346-52. PubMed ID: 6242085
[No Abstract] [Full Text] [Related]
5. Characterization of the human erythrocyte complement receptor CR1 (C3b receptor) by epitope mapping.
Prohaska R; Adolf GR
Immunobiology; 1987 Jan; 174(1):93-106. PubMed ID: 2437016
[TBL] [Abstract][Full Text] [Related]
6. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
Forslid J; Hed J; Stendahl O
Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
[TBL] [Abstract][Full Text] [Related]
8. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.
Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F
Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte CR1 determination using monoclonal antibody in a microtiter plate ELISA; receptors are not masked by immune complexes.
Thomsen BS; Nielsen H; Bendixen G
Allergy; 1986 Sep; 41(7):479-86. PubMed ID: 2947511
[TBL] [Abstract][Full Text] [Related]
11. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
12. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome.
Gaither TA; Gallin JI; Iida K; Nussenzweig V; Frank MM
Inflammation; 1984 Dec; 8(4):429-44. PubMed ID: 6240460
[TBL] [Abstract][Full Text] [Related]
15. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
17. Mouse monoclonal antibodies to the human C3b receptor.
Cook J; Fischer E; Boucheix C; Mirsrahi M; Jouvin MH; Weiss L; Jack RM; Kazatchkine MD
Mol Immunol; 1985 May; 22(5):531-9. PubMed ID: 3160931
[TBL] [Abstract][Full Text] [Related]
18. The human C3b receptor: function and role in human diseases.
Tausk F; Gigli I
J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
[TBL] [Abstract][Full Text] [Related]
19. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
